Flibanserin Patent Expiration
Flibanserin is Used for treating hypoactive sexual desire disorder (HSDD). It was first introduced by Sprout Pharmaceuticals Inc
Flibanserin Patents
Given below is the list of patents protecting Flibanserin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Addyi | US7151103 | Method of treating female hypoactive sexual desire disorder with flibanserin | May 09, 2028 | Sprout Pharms |
| Addyi | US8227471 | Treating sexual desire disorders with flibanserin |
May 09, 2023
(Expired) | Sprout Pharms |
| Addyi | US9468639 | Treating sexual desire disorders with flibanserin |
Oct 16, 2022
(Expired) | Sprout Pharms |
| Addyi | US7420057 | Stable polymorph of flibanserin |
Aug 01, 2022
(Expired) | Sprout Pharms |
Flibanserin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List